| Layla Renee Lundquist-smith, MD | |
|
609 E. Laurell Street, Atmore, AL 36502 | |
| (251) 368-6906 | |
| Not Available |
| Full Name | Layla Renee Lundquist-smith |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 609 E. Laurell Street, Atmore, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538452073 | NPI | - | NPPES |
| 012201600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME115631 (Florida) | Secondary |
| 207Q00000X | Family Medicine | MD.41738 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southerncare Greenville | Greenville, AL | Hospice |
| Atmore Community Hospital | Atmore, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Escambia County Alabama Community Hospitals, Inc | 4385616119 | 13 |
| Escambia County Alabama Community Hospitals, Inc | 4385616119 | 13 |
News Archive
The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials.
A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO).
California's health exchange said Wednesday it has ordered insurers to add a surcharge to certain policies next year because the Trump administration has yet to commit to paying a key set of consumer subsidies under the Affordable Care Act.
ChemoCentryx, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | Baptist Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376779892 PECOS PAC ID: 9638215734 Enrollment ID: O20091002000436 |
News Archive
The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials.
A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO).
California's health exchange said Wednesday it has ordered insurers to add a surcharge to certain policies next year because the Trump administration has yet to commit to paying a key set of consumer subsidies under the Affordable Care Act.
ChemoCentryx, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Layla Renee Lundquist-smith, MD 609 E Laurel St, Atmore, AL 36502-7567 Ph: (251) 368-6960 | Layla Renee Lundquist-smith, MD 609 E. Laurell Street, Atmore, AL 36502 Ph: (251) 368-6906 |
News Archive
The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials.
A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO).
California's health exchange said Wednesday it has ordered insurers to add a surcharge to certain policies next year because the Trump administration has yet to commit to paying a key set of consumer subsidies under the Affordable Care Act.
ChemoCentryx, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
William Shane Harigel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-7974 Fax: 251-368-5973 | |
Frances Delaine Salter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 6th Ave, Atmore, AL 36502 Phone: 251-368-8999 Fax: 251-368-8887 | |
Dr. Priscilla Beverly Durand-mitchelle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 706 E Laurel St, Atmore, AL 36502 Phone: 251-368-5117 Fax: 251-368-4021 | |
Sheldon Jon Harigel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Medical Park Drive, Atmore, AL 36502 Phone: 251-368-7974 Fax: 251-368-5973 | |
Dr. Jonathan Edward Yoder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-7974 Fax: 251-368-5973 | |
John P Mcguinness, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-6221 |